[1] ISPOR is the leading source for scientific conferences, peer-reviewed and indexed publications, good practices guidance, education, collaboration, and tools/resources in the field of HEOR.

[2][3][4][5][6][7][8] The society has also collaborated with the Academy of Managed Care Pharmacy to develop guidelines for training programs and fellowships for future professionals in pharmacoeconomics and outcomes research.

[9] An increasing number of new pharmaceuticals have used questionnaires to capture Patient-reported outcome (PROs) of health care as a metric to complement their clinical effectiveness.

[11] The International Society for Quality of Life Research (ISOQOL) developed a minimum set of measurement standards to properly use PRO instruments.

[12] Moreover, ISPOR developed a set of standards to properly test these instruments for reliability and validity, which has been adopted by the Food and Drug Administration (FDA).

[13] Currently, the FDA refers to the ISPOR Task Force's publications on content validity for the development of new clinical outcome assessment instruments or tools.

[26] On September 29, 2020, the organization held a joint summit with the Food and Drug Administration on the topic of patient preference information in medical device regulatory decisions.